Showing results (191-200 of 205) with videos related to

Sort By:
Pageof 21
Ophthalmology. Retina|December 12, 2022
Incidence and Risk Factors of Visual Impairment in Patients with Angioid Streaks and Macular NeovascularizationMaria Vittoria Cicinelli, Edoardo Torrioli, Lamberto La Franca, et al.
Acta Ophthalmologica|September 30, 2020
Genotype-phenotype spectrum in isolated and syndromic nanophthalmosElena Lang, Samuel Koller, David Atac, et al.
The British Journal of Ophthalmology|October 8, 2025
Minimum set of outcome measures for non-advanced age-related macular degeneration: a Delphi consensus statement by the TRACER (intermediate age-related macular degeneration) study groupMariano Cozzi, Sandrine Zweifel, Konstantinos Balaskas, et al.
The British Journal of Ophthalmology|March 13, 2021
Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registryAdrian R Hunt, Vuong Nguyen, Catherine P Creuzot-Garcher, et al.
Retina (Philadelphia, Pa.)|October 17, 2024
THE FIGHT INHERITED RETINAL BLINDNESS! PROJECT: A New Treatment Outcome and Natural History Registry for Inherited Retinal DiseaseMatthew P Simunovic, Anthony T Moore, John Grigg, et al.
Eye (London, England)|May 13, 2026
I-SCREEN: Development of an AI-based infrastructure for community-wide screening and prediction of progression in age-related macular degeneration providing accessible shared careMarie Louise Enzendorfer, Gregor S Reiter, Hrvoje Bogunović, et al.
American Journal of Ophthalmology|May 2, 2016
Defining a Minimum Set of Standardized Patient-centered Outcome Measures for Macular DegenerationIan A Rodrigues, Sara M Sprinkhuizen, Daniel Barthelmes, et al.
Ophthalmology. Retina|April 14, 2024
One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity: Data from the Fight Retinal Blindness! RegistryHemal Mehta, Pierre-Henry Gabrielle, Yohei Hashimoto, et al.
Microorganisms|September 27, 2025
Incidence of Acanthamoeba Keratitis in SwitzerlandFrank Blaser, Felix Grimm, Philipp B Baenninger, et al.
Investigative Ophthalmology & Visual Science|April 16, 2010
The PROM1 mutation p.R373C causes an autosomal dominant bull's eye maculopathy associated with rod, rod-cone, and macular dystrophyMichel Michaelides, Marie-Claire Gaillard, Pascal Escher, et al.
Pageof 21